Journal Article

Seroprevalence of Chronic Hepatitis B Virus Infection and Prior Immunity in Immigrants and Refugees: A Systematic Review and Meta-Analysis

Shrier, Ian, Klein, Marina B., Cnossen, Sonya, Greenaway, Chris, Schwartzman, Kevin, Rossi, Carmine, Schwarzer, Guido, Marshall, Lee

2012

Overview

International migrants experience increased mortality from hepatocellular carcinoma compared to host populations, largely due to undetected chronic hepatitis B infection (HBV). We conducted a systematic review of the seroprevalence of chronic HBV and prior immunity in migrants arriving in low HBV prevalence countries to identify those at highest risk in order to guide disease prevention and control strategies. Medline, Medline In-Process, EMBASE and the Cochrane Database of Systematic Reviews were searched. Studies that reported HBV surface antigen or surface antibodies in migrants were included. The seroprevalence of chronic HBV and prior immunity were pooled by region of origin and immigrant class, using a random-effects model. A random-effects logistic regression was performed to explore heterogeneity. The number of chronically infected migrants in each immigrant-receiving country was estimated using the pooled HBV seroprevalences and country-specific census data. A total of 110 studies, representing 209,822 immigrants and refugees were included. The overall pooled seroprevalence of infection was 7.2% (95% CI: 6.3%-8.2%) and the seroprevalence of prior immunity was 39.7% (95% CI: 35.7%-43.9%). HBV seroprevalence differed significantly by region of origin. Migrants from East Asia and Sub-Saharan Africa were at highest risk and migrants from Eastern Europe were at an intermediate risk of infection. Region of origin, refugee status and decade of study were independently associated with infection in the adjusted random-effects logistic model. Almost 3.5 million migrants (95% CI: 2.8-4.5 million) are estimated to be chronically infected with HBV. The seroprevalence of chronic HBV infection is high in migrants from most world regions, particularly among those from East Asia, Sub-Saharan Africa and Eastern Europe, and more than 50% were found to be susceptible to HBV. Targeted screening and vaccination of international migrants can become an important component of HBV disease control efforts in immigrant-receiving countries.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Africa South of the Sahara / Antibodies / Antigens / Asia, Eastern / Biology / Carcinoma, Hepatocellular - epidemiology / Carcinoma, Hepatocellular - virology / Census / Chronic infection / Comparative analysis / Control methods / Cost analysis / Data processing / Disease control / Disease prevention / Earth Sciences / Emigrants and Immigrants / Epidemiology / Europe, Eastern / Geography / Health aspects / Health risk assessment / Health risks / Hepatitis / Hepatitis B / Hepatitis B virus / Hepatitis B virus - metabolism / Hepatitis B, Chronic - blood / Hepatitis B, Chronic - complications / Hepatitis B, Chronic - virology / Hepatocellular carcinoma / Heterogeneity / Hospitals / Humans / Immigrants / Immigration policy / Immunity / Infections / Infectious diseases / Liver cancer / Liver Neoplasms - epidemiology / Liver Neoplasms - virology / Medical research / Medicine / Meta-analysis / Migrants / Mortality / Noncitizens / Occupational health / Prevalence / Prevention / Refugees / Regression Analysis / Regression models / Reviews / Risk / Risk factors / Seroepidemiologic Studies / Serology / Studies / surface antigens / Systematic review / Vaccination / Viral infections / Viruses